GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes

PURPOSE: To find genetic variants that predicted toxicity and/or efficacy of paclitaxel plus carboplatin combination therapy (TC therapy). PATIENTS AND METHODS: In a retrospective case-control study, we analyzed 320 patients who had received TC therapy for gynecological cancers (ovarian, fallopian t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Yoshihama, Tomoko, Fukunaga, Koya, Hirasawa, Akira, Nomura, Hiroyuki, Akahane, Tomoko, Kataoka, Fumio, Yamagami, Wataru, Aoki, Daisuke, Mushiroda, Taisei
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049855/
https://ncbi.nlm.nih.gov/pubmed/30038720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados